Newton Charles W. bought KROS
March 9, 2026 · Form 4 insider transaction
Newton Charles W. bought 14,788 shares of Keros Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
14,788
Price
$0.00
Total value
N/A
InsiderNewton Charles W.
RoleOfficer, Director
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 9, 2026
Filing dateMarch 11, 2026
Shares owned after14,788
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares subject to the option shall vest over a three-year period in equal quarterly installments with the first such vesting to occur on June 9, 2026, subject to the Reporting Person's continuous service through each such vesting date.